期刊文献+

肿瘤药物敏感性试验方法研究进展 被引量:2

Study Progress of Tumor Drug Sensitivity Test Method
下载PDF
导出
摘要 近30年来各国学者开发出多种体外、体内肿瘤药物敏感性预测试验,给传统的化疗观念来了改变和挑战。本文结合最新研究进展,综述了6种肿瘤药物敏感性试验方法的研究背景、基本原理和优缺点。 In the past 30 years, foreign scholars invented all kinds of chemosensitivity assay of tumor drug applied both inside and outside of body, which bring changes and challenges to traditional concepts of chemiotherapy. Combining the latest progress in research,This article reviewed the study background ,basic principle, advantages and disadvantages of six kinds of chemosemitivity assay of tumor drug.
作者 卢毅卓 罗琪
出处 《医学综述》 2007年第7期551-553,共3页 Medical Recapitulate
关键词 肿瘤 药敏实验 药物疗法 Tumor Chemosensitivity assay Drug therapy
  • 相关文献

参考文献18

  • 1Kondo T,Kubota T,Tanimura T,et al.Cumulative result of chemosensitivity tests for antitumoragents in Japan[J].Anti Cancer Res,2000,20(3):2389-2392.
  • 2Von Hoff DD,Clark GM,Stogdill BJ,et al.Prospective clinical trial of a human tumor cloning system[J].Cancer Res,1983,4(3):1926-1931.
  • 3钱晓蕾,彭芝兰,刘珊玲,王和,倪俭,程易凡.ATP和MTT法在卵巢恶性肿瘤化疗药物敏感性试验中的对照研究[J].中华肿瘤杂志,2002,24(2):204-205. 被引量:17
  • 4Hwang WS,Chen LM,Huang SH,et al.Prediction of chemotherapy respons in human leukemia using in vitro chemosensitivity test[J].Leuk Res,1993,17(8):685-688.
  • 5周载平,胡泽民,季明芳,余元龙,常晓健,陈宏.三磷酸腺苷生物荧光法检测肿瘤药敏的价值[J].肿瘤防治杂志,2003,10(7):689-691. 被引量:11
  • 6Kurbacher CM,Grecu OM,Stier U,et al.ATP chemosensitivity testing in ovarian and breast cancer:early clinical trials[J].Recent Results Cancer Res,2003,16(1):221-230.
  • 7管睿,崔英.ATP-CSA化疗药物敏感试验及在卵巢癌中的应用[J].国外医学(临床生物化学与检验学分册),2003,24(5):291-292. 被引量:4
  • 8Tewari K,Manetta A.In vitro chemosensitivity testing and mechanisms of drug resistance[J].Curr Oncol Rep,1999,1(1):77-84.
  • 9Takamura Y,Kobayashi H,Taguchi T,et al.Prediction of chemotherapeutic response by collagen gel droplet embedded culture-drug sensitivity test in human breast cancers[J].Cancer,2002,18(3):450-455.
  • 10Kobayashi H,Tanisaka K,Doi O,et al.An invitro chemosensitivity test for human tumors using collagen gel droplet embedded cultures[J].Int Oncol,1997,1(1):449-455.

二级参考文献30

  • 1梁永钜,潘启超,麦伟源,闵华庆.鼻咽癌体外药物敏感性试验方法的初步研究[J].癌症,1996,15(3):216-218. 被引量:16
  • 2赖启明,金宝翠,刘立华.ATP生物发光测定白血病细胞体外药物敏感试验[J].南京铁道医学院学报,1996,15(2):74-75. 被引量:3
  • 3O'Meara AT,Sevin BU. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer[J]. Gynecol Oncol,2001,83(2) :334-342.
  • 4Sevin BU, Peng ZL, Perras JP, et al. Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing[J]. Gynecol Oncol, 1988,31 (1) : 191-204.
  • 5Sevin BU, Perras JP, Averette HE, et al. Chemosensitivity testing in ovarian cancer[J]. Cancer, 1993,71 (4) : 1613-1620.
  • 6Ng TY, Ngan HY, Cheng DK, et al. Clinical applicability of the ATP cell viability assay as a predictor of chemoresponse in platinum-resistant epithelial ovarian cancer usign nonsurgical tumor cell samples[J]. Gynecol Oncol,2000,76(3) :405-408.
  • 7Sevin BU, Perras JP. Tumor heterogeneity and in vitro chemosensitivity testing in ovarian cancer[Jl. Am J Obstet Gynecol, 1997,176(4) : 759-766.
  • 8Kurbacher CM, Cree IA, Bruckner HW, et al. Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer[J]. Anticancer Drugs, 1998,9(1) :51-57.
  • 9Breidenbach M, Rein DT, Mallmann P, et al. Individualized long-term chemotherapy for recurrent ovarian cancer after failing high-dose treatment[J]. Anticancer Drugs,2002,13(2):173-176.
  • 10O'meara AT,Sevin BU. In vitro sensitivity of fresh ovarian carcinoma specimens to CPT-11(irinotecan) [J]. Gynecol Oncol, 1999,72(2) : 143-147.

共引文献44

同被引文献22

  • 1Andy Ramlatchan,Mengyun Yang,Quan Liu,Min Li,Jianxin Wang,Yaohang Li.A Survey of Matrix Completion Methods for Recommendation Systems[J].Big Data Mining and Analytics,2018,1(4):308-323. 被引量:4
  • 2王辉,崔泽实.肿瘤耐药基因的研究进展[J].国际病理科学与临床杂志,2007,27(3):239-244. 被引量:4
  • 3Tetsuvo kubota, Larry weisenthal. Chemotherapy Sensi tivity and Resistance Assays[J]. Tecnologica MAP Suppl, 2000, 19(2):3-6.
  • 4Schrag D, Garewal HS, Burstein HJ, et al. American so- ciety of clinical oncology technology assessment: chemoth- erapy sensitivity and resistance assays[J]. J Clin oncol, 2004, 22(17) :3631-3638.
  • 5Gree LA. Predictive oncology-second conterence of the international society for chemosensitivity testing in oncolo- gy[J]. Anticancer Drugs, 2004, 15(3):301.
  • 6Mosmann T. Rapid colorimetric assay for celular growth and survival: application to proliferation and cytotoxicity assay[J]. Immunol Meth, 1983, 65(1-2):55-63.
  • 7Hof~an RdVI. In vitro sensitivity assays in cancer: A re- view,analysis and prognosis[J]. Clin.Lab.Anal, 1991, 5(2): 133-143.
  • 8Hoffrnan RM. In vitro assays for chemotherapy sensitivity [J]. Crit. Rev. Oncol. Hematol, 1993, 15(3): 99-111.
  • 9Juliano R_L, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell muants [J]. Biohim Biophys Acta, 1976, 455(1): 152-162.
  • 10R.icardo P. Multidrug resistence retrospect and prospects in anticancer drug treatment[J]. Curr Med Chem, 2006, 13 (16): 1859-1876.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部